Paper II
2022 May (Supplementary) (2010 Scheme)
Question
Dimercaprol
Q131 marksShort Answers
Answer
Uses: Arsenic poisoning; Mercury and lead poisoning (with EDTA for lead)
Adverse effects: Pain at the intramuscular injection site; Hypertension and tachycardia
Related Concepts
Other Years Asked
- 1Define a receptor. Discuss the various transducer mechanisms by which the receptors act. (1+5)2018 July (Supplementary) (2010 Scheme)Essay · 6 marks
- 2Drug antagonism.2025 August (Supplementary) (2010 Scheme)Short Note · 3 marks
- 3Drug antagonism.2015 February (2010 Scheme)Short Note · 3 marks
- 4Drug Antagonism2023 July (Supplementary) (2010 Scheme)Short Note · 3 marks
- 5Drug antagonism2021 May (Supplementary) (2010 Scheme)Short Note · 3 marks
- 6Drug antagonism2017 February (2010 Scheme)Short Note · 3 marks
- 7G-protein coupled receptors2020 February (Supplementary) (2010 Scheme)Short Note · 3 marks
- 8Assertion (A): Allopurinol can precipitate acute gout. Reason (R): Inhibition of uric acid synthesis mobilizes tissue store of uric acid in to plasma.2025 March (Supplementary (SAY)) (2019 Scheme)MCQ (A/R) · 1 mark
- 9Assertion (A): Propranolol is often used to manage symptoms of hyperthyroidism. Reason (R): Propranolol is a non-selective beta-blocker that reduces the symptoms of hyperthyroidism by blocking the effects of excessive thyroid hormones on the heart.2025 March (Supplementary (SAY)) (2019 Scheme)MCQ (A/R) · 1 mark
- 10Drug induced parkinsonism2013 April (2010 Scheme)Short Answer · 1 mark
- 11Assertion (A): Beta-2 agonists, such as salbutamol, are used to treat asthma. Reason (R): Beta-2 agonists work by stimulating beta-2 adrenergic receptors on bronchial smooth muscles, causing bronchodilation.2025 March (Supplementary (SAY)) (2019 Scheme)MCQ (A/R) · 1 mark
- 12Substances that precipitate superficial surface proteins without penetrating the cells and toughen the skin making it mechanically stronger and decrease exudation are called:2024 December (Supplementary) (2019 Scheme)MCQ · 1 mark
- 13Disease modifying anti-rheumatic drugs2018 February (2010 Scheme)Short Answer · 1 mark
- 14Potassium channel openers2021 May (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 15Potassium channel openers2021 December (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 16Epidermal growth factor receptor inhibitors2022 February (2019 Scheme)Short Answer · 0.2 marks

